Nature Reviews Immunology

Papers
(The H4-Index of Nature Reviews Immunology is 100. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
A guide to cancer immunotherapy: from T cell basic science to clinical practice2201
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages1805
Viral targets for vaccines against COVID-19803
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity802
COVID-19: the vasculature unleashed776
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape773
Immunological considerations for COVID-19 vaccine strategies766
The cGAS–STING pathway as a therapeutic target in inflammatory diseases762
A guide to vaccinology: from basic principles to new developments724
T cell responses in patients with COVID-19671
Considering how biological sex impacts immune responses and COVID-19 outcomes647
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19596
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities575
Neutralizing monoclonal antibodies for treatment of COVID-19550
COVID-19 vaccines: modes of immune activation and future challenges521
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?447
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans426
Tissue damage from neutrophil-induced oxidative stress in COVID-19420
Inflammation and immune dysfunction in Parkinson disease402
COVID-19 herd immunity: where are we?396
CD8+ T cell differentiation and dysfunction in cancer372
BCG-induced trained immunity: can it offer protection against COVID-19?364
Dysregulation of type I interferon responses in COVID-19353
The role of IgG Fc receptors in antibody-dependent enhancement338
Lactate modulation of immune responses in inflammatory versus tumour microenvironments337
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy335
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns322
The first 12 months of COVID-19: a timeline of immunological insights320
The type I interferon response in COVID-19: implications for treatment306
Mucosal vaccines — fortifying the frontiers295
The inflammatory pathogenesis of colorectal cancer285
Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children264
The roles of extracellular vesicles in the immune system251
Metabolic barriers to cancer immunotherapy251
Neutrophils in cancer: heterogeneous and multifaceted248
γδ T cells in tissue physiology and surveillance242
Fibroblasts as immune regulators in infection, inflammation and cancer238
Interferon-γ: teammate or opponent in the tumour microenvironment?233
Not just antibodies: B cells and T cells mediate immunity to COVID-19233
Redox regulation of immunometabolism228
COVID-19: a case for inhibiting IL-17?227
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection219
A guide to antigen processing and presentation218
Regulation of immune responses by the airway epithelial cell landscape217
Cross-reactive memory T cells and herd immunity to SARS-CoV-2217
Mitochondrial control of inflammation216
Inflammasome activation at the crux of severe COVID-19216
Natural killer cells in antiviral immunity210
Immunobiology and pathogenesis of hepatitis B virus infection207
Monkeypox: disease epidemiology, host immunity and clinical interventions205
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact205
CD8+ T cell metabolism in infection and cancer201
IL-17 and IL-17-producing cells in protection versus pathology200
Dissecting antibody-mediated protection against SARS-CoV-2200
Targeting CD39 in cancer188
Immune cell-mediated features of non-alcoholic steatohepatitis187
Regulation of inflammation by the antioxidant haem oxygenase 1180
How the immune system shapes atherosclerosis: roles of innate and adaptive immunity175
Neuromodulation by the immune system: a focus on cytokines170
The type I interferonopathies: 10 years on169
Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge168
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches168
Transcriptional regulation of memory B cell differentiation166
The state of complement in COVID-19163
Genetic models of human and mouse dendritic cell development and function158
Constitutive immune mechanisms: mediators of host defence and immune regulation155
Autoantibodies in neurological disease151
The germinal centre B cell response to SARS-CoV-2151
Will SARS-CoV-2 variants of concern affect the promise of vaccines?149
A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion147
Early life microbial exposures and allergy risks: opportunities for prevention146
How transcription factors drive choice of the T cell fate144
Understanding COVID-19-associated coagulopathy142
Immunomodulation by endothelial cells — partnering up with the immune system?140
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections140
Death by TNF: a road to inflammation139
Immune ageing at single-cell resolution134
Regulation of the nucleic acid-sensing Toll-like receptors133
Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders132
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses129
Milder disease with Omicron: is it the virus or the pre-existing immunity?124
Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey124
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy124
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19123
Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms118
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?116
Engineering IL-2 for immunotherapy of autoimmunity and cancer115
Tissue regulatory T cells: regulatory chameleons113
Are COVID-19 vaccines safe in pregnancy?109
Immune-mediated inflammatory disease therapeutics: past, present and future109
The impact of the gut microbiome on extra-intestinal autoimmune diseases109
NOD-like receptor-mediated plant immunity: from structure to cell death108
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models107
Author Correction: Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages106
Bacterial origins of human cell-autonomous innate immune mechanisms105
Glucocorticoids in T cell development, differentiation and function105
TCF1 in T cell immunity: a broadened frontier102
Is IL-6 a key cytokine target for therapy in COVID-19?102
The immunology of multiple sclerosis102
Neuronal regulation of immunity: why, how and where?100
0.052731037139893